GleamWall
中文EN

PGNY Progyny, Inc.

Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1551306 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.5%
TTM net income YoY60.9%
TTM EPS YoY73.0%
Revenue 3-yr CAGR9.0%
Net income 3-yr CAGR20.5%

Margins

Gross margin24.9%
Operating margin9.4%
Net margin6.8%
FCF margin13.4%
EBITDA margin9.9%

Returns

ROE18.7%
ROA12.4%
ROIC (approx.)23.9%
Asset turnover1.82x

Leverage & solvency

Liabilities / assets38.7%
Debt / equity0.00x
Current ratio1.93x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.28x
Accruals ratio-15.8%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q42025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q42024-12-31
Income statement
Revenue$341.25M$350.51M$328.50M$318.40M$313.35M$332.87M$324.04M$298.43M
Cost of revenue$257.51M$261.21M$245.43M$241.52M$240.51M$253.90M$248.24M$235.00M
Gross profit$83.74M$89.30M$83.07M$76.88M$72.83M$78.97M$75.80M$63.43M
R&D expense$3.10M$3.30M$2.80M$3.10M$2.60M$2.30M$1.50M—
SG&A expense$30.50M$31.22M$30.81M$43.67M$33.37M$36.21M$33.84M$32.03M
Operating income$35.18M$40.00M$35.38M$15.22M$21.53M$24.36M$24.17M$15.79M
Pretax income$36.42M$41.14M$36.88M$17.85M$23.96M$27.08M$26.54M$17.66M
Income tax$10.16M$13.09M$12.65M$5.37M$10.10M$9.96M$11.48M$7.13M
Net income$26.25M$28.05M$24.23M$12.48M$13.86M$17.11M$15.06M$10.53M
EBITDA$37.33M$41.63M$36.86M$16.59M$22.80M$25.56M$25.28M$16.66M
EPS (basic)0.340.360.300.150.160.200.180.12
EPS (diluted)0.320.340.290.140.150.190.170.12
Weighted avg. shares (diluted)81.17M82.14M84.76M89.46M90.23M89.64M89.31M88.91M
Balance sheet
Cash & equivalents$116.82M$152.63M$131.61M$112.24M$133.98M$132.51M$109.24M$162.31M
Short-term investments$78.77M$84.29M$93.50M$197.86M$211.22M$172.59M$146.88M$65.64M
Receivables$249.18M$257.48M$263.61M$220.29M$252.50M$271.85M$299.74M$235.32M
Current assets$464.40M$513.02M$501.55M$551.77M$622.01M$594.40M$567.69M$472.72M
PP&E, net$50.25M$41.99M$35.71M$29.93M$24.74M$19.94M$15.74M$12.38M
Goodwill$19.83M$19.85M$19.88M$19.98M$19.96M$19.96M$19.65M$15.53M
Intangibles$5.53M$5.75M$5.97M$6.22M$6.43M$6.64M$6.75M$1.30M
Total assets$675.79M$715.84M$698.34M$742.43M$795.23M$760.95M$730.28M$607.10M
Current liabilities$240.04M$240.08M$235.74M$202.39M$210.49M$220.42M$237.13M$168.63M
Total liabilities$261.76M$262.58M$258.99M$226.39M$235.22M$245.93M$263.13M$185.04M
Shareholders' equity$414.03M$453.26M$439.34M$516.04M$560.00M$515.02M$467.16M$422.06M
Shares outstanding74.72M77.39M78.27M83.37M86.15M85.93M85.67M85.31M
Cash flow statement
Operating cash flow$56.60M$50.42M$45.95M$54.20M$50.67M$55.51M$49.81M$52.16M
Capital expenditure$9.37M$6.22M$6.35M$5.61M$4.68M$5.27M$2.84M$1.90M
Free cash flow$47.24M$44.21M$39.60M$48.59M$45.99M$50.24M$46.97M$50.27M
Investing cash flow-$5.02M$3.55M$96.59M$8.26M-$42.74M-$29.91M-$94.61M$74.99M
Financing cash flow-$87.40M-$32.89M-$123.11M-$88.26M-$5.49M-$2.33M-$3.29M-$56.33M
Depreciation & amortization$2.15M$1.62M$1.48M$1.37M$1.27M$1.21M$1.11M$868,000
Stock-based compensation$21.11M$20.48M$19.72M$34.80M$32.17M$32.38M$32.51M$30.86M
Share buybacks$82.78M$30.02M$118.61M$81.66M$0$0$0$55.10M

Free plan shows the latest 8 periods; Pro shows all 35 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.